- ORCID iD
- 0000-0003-0006-8104
Show
Sort by
-
- Journal Article
- A1
- open access
Preclinical activity of two paclitaxel nanoparticle formulations after intraperitoneal administration in ovarian cancer murine xenografts
-
- Journal Article
- A1
- open access
Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
-
- Journal Article
- A1
- open access
The feasibility of pressurised intraperitoneal aerosolised virotherapy (PIPAV) to administer oncolytic adenoviruses
-
- Conference Paper
- C3
- open access
Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study
-
Pressurized intraperitoneal aerosol chemotherapy for the treatment of irresectable peritoneal metastasis
(2020) -
- Conference Paper
- C3
- open access
Effects of electrostatic precipitation on IP drug distribution and tissue penetration of nanoparticles
-
Intraperitoneal aerosolized drug delivery : technology, recent developments, and future outlook
-
Electrostatic precipitation is a valuable adjunct to pressurized intraperitoneal aerosol chemotherapy : an in vitro study
-
- Journal Article
- A1
- open access
Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine : cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer
-
Electrostatic intraperitoneal aerosol delivery of nanoparticles : proof of concept and preclinical validation